Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.3900 (-4.91%) ($11.6200 - $13.1100) on Fri. Jul. 31, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.75% (three month average) | RSI | 37 | Latest Price | $12.3900(-4.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -2.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(44%) IBB(44%) ARKK(43%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.375% in a week (0% probabilities). VIXM(-31%) VXX(-26%) XLC(-10%) UNG(-9%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.375% (StdDev 6.75%) | Hourly BBV | 0 () | Intraday Trend | -4.8% | | | |
|
1 - 5 Day Possible Target | $1.19(-90.4%) | Resistance Level | $13.89 | 5 Day Moving Average | $12.99(-4.62%) | 10 Day Moving Average | $13.4(-7.54%) | 20 Day Moving Average | $13.89(-10.8%) | To recent high | -20.1% | To recent low | 56.4% | Market Cap | $921m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |